INVENTRONICS LTD (IVX.CA) Stock Fundamental Analysis

TSX-V:IVX • CA4612082095

0.78 CAD
+0.01 (+1.3%)
Last: Feb 19, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

IVX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 3 industry peers in the Building Products industry. IVX has an excellent profitability rating, but there are some minor concerns on its financial health. IVX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year IVX was profitable.
  • IVX had a positive operating cash flow in the past year.
  • IVX had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years IVX had a positive operating cash flow.
IVX.CA Yearly Net Income VS EBIT VS OCF VS FCFIVX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M

1.2 Ratios

  • With an excellent Return On Assets value of 3.06%, IVX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • With an excellent Return On Equity value of 7.03%, IVX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 5.32%, IVX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for IVX is significantly above the industry average of 5.32%.
  • The last Return On Invested Capital (5.32%) for IVX is well below the 3 year average (16.93%), which needs to be investigated, but indicates that IVX had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.06%
ROE 7.03%
ROIC 5.32%
ROA(3y)13.23%
ROA(5y)18.83%
ROE(3y)27.58%
ROE(5y)43.53%
ROIC(3y)16.93%
ROIC(5y)16.61%
IVX.CA Yearly ROA, ROE, ROICIVX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.38%, IVX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • IVX has a better Operating Margin (4.99%) than 100.00% of its industry peers.
  • In the last couple of years the Operating Margin of IVX has declined.
  • IVX's Gross Margin of 19.10% is on the low side compared to the rest of the industry. IVX is outperformed by 66.67% of its industry peers.
  • In the last couple of years the Gross Margin of IVX has declined.
Industry RankSector Rank
OM 4.99%
PM (TTM) 2.38%
GM 19.1%
OM growth 3Y-64.43%
OM growth 5Y-35.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.48%
GM growth 5Y-3.82%
IVX.CA Yearly Profit, Operating, Gross MarginsIVX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IVX is creating value.
  • Compared to 1 year ago, IVX has about the same amount of shares outstanding.
  • Compared to 5 years ago, IVX has more shares outstanding
  • Compared to 1 year ago, IVX has an improved debt to assets ratio.
IVX.CA Yearly Shares OutstandingIVX.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
IVX.CA Yearly Total Debt VS Total AssetsIVX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • An Altman-Z score of 2.74 indicates that IVX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of IVX (2.74) is better than 66.67% of its industry peers.
  • The Debt to FCF ratio of IVX is 4.04, which is a neutral value as it means it would take IVX, 4.04 years of fcf income to pay off all of its debts.
  • IVX's Debt to FCF ratio of 4.04 is on the low side compared to the rest of the industry. IVX is outperformed by 66.67% of its industry peers.
  • A Debt/Equity ratio of 0.77 indicates that IVX is somewhat dependend on debt financing.
  • IVX has a Debt to Equity ratio of 0.77. This is in the lower half of the industry: IVX underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 4.04
Altman-Z 2.74
ROIC/WACC0.67
WACC7.95%
IVX.CA Yearly LT Debt VS Equity VS FCFIVX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.3 Liquidity

  • IVX has a Current Ratio of 2.65. This indicates that IVX is financially healthy and has no problem in meeting its short term obligations.
  • IVX has a better Current ratio (2.65) than 100.00% of its industry peers.
  • A Quick Ratio of 1.88 indicates that IVX should not have too much problems paying its short term obligations.
  • IVX has a Quick ratio of 1.88. This is amongst the best in the industry. IVX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.65
Quick Ratio 1.88
IVX.CA Yearly Current Assets VS Current LiabilitesIVX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • IVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 825.93%, which is quite impressive.
  • IVX shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.07%.
  • IVX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.21% yearly.
EPS 1Y (TTM)825.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%259.38%
Revenue 1Y (TTM)35.07%
Revenue growth 3Y-13.78%
Revenue growth 5Y2.21%
Sales Q2Q%29.55%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IVX.CA Yearly Revenue VS EstimatesIVX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.50, the valuation of IVX can be described as rather expensive.
  • IVX's Price/Earnings ratio is rather cheap when compared to the industry. IVX is cheaper than 100.00% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of IVX to the average of the S&P500 Index (27.11), we can say IVX is valued slightly cheaper.
Industry RankSector Rank
PE 19.5
Fwd PE N/A
IVX.CA Price Earnings VS Forward Price EarningsIVX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • IVX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IVX is cheaper than 100.00% of the companies in the same industry.
  • 100.00% of the companies in the same industry are more expensive than IVX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.69
EV/EBITDA 8.47
IVX.CA Per share dataIVX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The decent profitability rating of IVX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • IVX has a Yearly Dividend Yield of 23.33%, which is a nice return.
  • IVX's Dividend Yield is rather good when compared to the industry average which is at 7.78. IVX pays more dividend than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, IVX pays a better dividend.
Industry RankSector Rank
Dividend Yield 23.33%

5.2 History

  • IVX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IVX.CA Yearly Dividends per shareIVX.CA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
IVX.CA Yearly Income VS Free CF VS DividendIVX.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K 1M 1.5M 2M

More info and screens

Find the best dividend stocksShow peers with best dividend

INVENTRONICS LTD

TSX-V:IVX (2/19/2026, 7:00:00 PM)

0.78

+0.01 (+1.3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.93%
Ins Owner ChangeN/A
Market Cap3.80M
Revenue(TTM)8.02M
Net Income(TTM)191.00K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 23.33%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 19.5
Fwd PE N/A
P/S 0.47
P/FCF 6.69
P/OCF 6.01
P/B 1.4
P/tB 1.4
EV/EBITDA 8.47
EPS(TTM)0.04
EY5.13%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.12
FCFY14.95%
OCF(TTM)0.13
OCFY16.64%
SpS1.65
BVpS0.56
TBVpS0.56
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.71
Profitability
Industry RankSector Rank
ROA 3.06%
ROE 7.03%
ROCE 7.89%
ROIC 5.32%
ROICexc 6.85%
ROICexgc 6.85%
OM 4.99%
PM (TTM) 2.38%
GM 19.1%
FCFM 7.08%
ROA(3y)13.23%
ROA(5y)18.83%
ROE(3y)27.58%
ROE(5y)43.53%
ROIC(3y)16.93%
ROIC(5y)16.61%
ROICexc(3y)18.71%
ROICexc(5y)18%
ROICexgc(3y)18.71%
ROICexgc(5y)18%
ROCE(3y)25.1%
ROCE(5y)24.63%
ROICexgc growth 3Y-68.88%
ROICexgc growth 5Y-39.12%
ROICexc growth 3Y-68.88%
ROICexc growth 5Y-39.12%
OM growth 3Y-64.43%
OM growth 5Y-35.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.48%
GM growth 5Y-3.82%
F-Score7
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 4.04
Debt/EBITDA 3.59
Cap/Depr 34.41%
Cap/Sales 0.8%
Interest Coverage 2.86
Cash Conversion 107.85%
Profit Quality 297.38%
Current Ratio 2.65
Quick Ratio 1.88
Altman-Z 2.74
F-Score7
WACC7.95%
ROIC/WACC0.67
Cap/Depr(3y)281.39%
Cap/Depr(5y)239.45%
Cap/Sales(3y)5.39%
Cap/Sales(5y)4.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)825.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%259.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.07%
Revenue growth 3Y-13.78%
Revenue growth 5Y2.21%
Sales Q2Q%29.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y250.88%
EBIT growth 3Y-69.33%
EBIT growth 5Y-34.39%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.83%
FCF growth 3Y-16.33%
FCF growth 5Y11.05%
OCF growth 1Y-75.44%
OCF growth 3Y-11.65%
OCF growth 5Y14.04%

INVENTRONICS LTD / IVX.CA FAQ

What is the ChartMill fundamental rating of INVENTRONICS LTD (IVX.CA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to IVX.CA.


What is the valuation status for IVX stock?

ChartMill assigns a valuation rating of 4 / 10 to INVENTRONICS LTD (IVX.CA). This can be considered as Fairly Valued.


How profitable is INVENTRONICS LTD (IVX.CA) stock?

INVENTRONICS LTD (IVX.CA) has a profitability rating of 7 / 10.


What is the valuation of INVENTRONICS LTD based on its PE and PB ratios?

The Price/Earnings (PE) ratio for INVENTRONICS LTD (IVX.CA) is 19.5 and the Price/Book (PB) ratio is 1.4.


Is the dividend of INVENTRONICS LTD sustainable?

The dividend rating of INVENTRONICS LTD (IVX.CA) is 5 / 10 and the dividend payout ratio is 0%.